Fortis Malar Hospitals Ltd
FORTISMLRFortis Malar Hospitals Ltd
FORTISMLR
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
LowUndervalued compared to the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 2.35 | 1.07 | 67.86% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.53 | 6.56 | 0.52% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Fortis Malar Hospitals Limited is a provider of super specialty and multi-specialty healthcare services. It is engaged in establishing hospitals and clinics to conduct healthcare for the society in various branches of medicine.
Peers
Compare with peersMax Healthcare Institute Ltd
Apollo Hospitals Enterprise Ltd
Fortis Healthcare Ltd
Global Health Ltd
Dr. Lal PathLabs Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 137.64 | 148.53 | 157.63 | 154.70 | 123.06 | 84.34 | 93.57 | 92.59 | 123.89 | 85.44 | ||||||||||
Raw Materials | 28.53 | 29.42 | 32.77 | 33.02 | 20.97 | 14.38 | 17.26 | 11.90 | 8.70 | 25.06 | ||||||||||
| Power & Fuel Cost | 2.76 | 2.74 | 2.82 | 3.19 | 3.04 | 2.67 | 2.59 | 2.93 | 2.47 | |||||||||||
| Employee Cost | 17.83 | 20.11 | 21.87 | 23.46 | 21.55 | 18.25 | 18.60 | 19.41 | 15.16 | |||||||||||
| Selling & Administrative Expenses | 28.90 | 79.00 | 40.11 | 50.72 | 33.86 | 21.43 | 20.56 | 22.25 | 17.49 | |||||||||||
| Operating & Other expenses | 46.10 | 8.40 | 49.87 | 36.62 | 35.23 | 18.85 | 23.73 | 24.88 | 16.39 | |||||||||||
EBITDA | 13.52 | 8.86 | 10.19 | 7.69 | 8.41 | 8.76 | 10.83 | 11.22 | 63.68 | 60.38 | ||||||||||
| Depreciation/Amortization | 3.16 | 3.94 | 4.21 | 4.38 | 12.53 | 12.88 | 12.53 | 12.15 | 9.36 | 3.97 | ||||||||||
| PBIT | 10.36 | 4.92 | 5.98 | 3.31 | -4.12 | -4.12 | -1.70 | -0.93 | 54.32 | 56.41 | ||||||||||
| Interest & Other Items | 0.40 | 0.46 | 0.38 | 0.51 | 7.81 | 7.20 | 6.56 | 6.07 | 4.30 | 1.66 | ||||||||||
| PBT | 9.96 | 4.46 | 5.60 | 2.80 | -11.93 | -11.32 | -8.26 | -7.00 | 50.02 | 54.75 | ||||||||||
| Taxes & Other Items | 3.54 | 1.35 | 2.27 | 0.73 | -3.04 | -3.45 | 0.01 | 8.48 | 4.68 | 4.68 | ||||||||||
| Net Income | 6.42 | 3.11 | 3.33 | 2.07 | -8.89 | -7.87 | -8.27 | -15.48 | 45.34 | 50.07 | ||||||||||
| EPS | 3.45 | 1.67 | 1.78 | 1.10 | -4.74 | -4.19 | -4.41 | -8.25 | 24.15 | 26.67 | ||||||||||
| DPS | 0.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 42.50 | 42.50 | ||||||||||
| Payout ratio | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.76 | 1.59 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Fortis Malar Hospitals Ltd | 2.59 | 1.07 | 67.86% |
| Max Healthcare Institute Ltd | 102.68 | 12.92 | 0.13% |
| Apollo Hospitals Enterprise Ltd | 116.14 | 14.26 | 0.22% |
| Fortis Healthcare Ltd | 89.98 | 6.30 | 0.14% |
Price Comparison
Compare FORTISMLR with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Increased Total Retail Holding
In last 3 months, retail holding in the company has increased by 2.39%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateJul 24, 2024
Dividend/Share
₹2.50
Ex DateEx Date
Jul 24, 2024
Cash Dividend
Ex DateEx DateApr 23, 2024
Dividend/Share
₹40.00
Ex DateEx Date
Apr 23, 2024
Cash Dividend
Ex DateEx DateSep 14, 2015
Dividend/Share
₹0.50
Ex DateEx Date
Sep 14, 2015
Cash Dividend
Ex DateEx DateSep 19, 2013
Dividend/Share
₹0.50
Ex DateEx Date
Sep 19, 2013
Net profit of Fortis Malar Hospitals reported to Rs 0.09 crore in the quarter ended September 2024 as against net loss of Rs 1.79 crore during the previous quarter ended September 2023. There were no Sales reported in the quarter ended September 2024 as against Rs 18.15 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales018.15 -100 OPM %0-0.44 - PBDT0.090.93 -90 PBT0.09-1.79 LP NP0.09-1.79 LP Powered by Capital Market - Live
Fortis Malar Hospitals will hold a meeting of the Board of Directors of the Company on 5 November 2024Powered by Capital Market - Live
Fortis Malar Hospitals reports consolidated net loss of Rs 0.06 crore in the June 2024 quarter
Net Loss of Fortis Malar Hospitals reported to Rs 0.06 crore in the quarter ended June 2024 as against net loss of Rs 2.93 crore during the previous quarter ended June 2023. There were no Sales reported in the quarter ended June 2024 as against Rs 17.76 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales017.76 -100 OPM %0-2.87 - PBDT-0.06-0.25 76 PBT-0.06-2.92 98 NP-0.06-2.93 98 Powered by Capital Market - Live
Fortis Malar Hospitals will hold a meeting of the Board of Directors of the Company on 22 July 2024.Powered by Capital Market - Live
Fortis Malar Hospitals reports consolidated net loss of Rs 1.15 crore in the December 2022 quarter
Fortis Malar Hospitals appoints Chandrasekar Ramasamy as Whole Time Director and KMP
Fortis Malar Hospitals reports consolidated net loss of Rs 3.78 crore in the September 2021 quarter
Top stocks in focus: Aarey Drugs & Pharmaceuticals, Fortis Malar Hospitals, Nath Bio-Genes, Pricol, Gujarat Alkalies and Chemicals
Fortis Malar Hospitals reports consolidated net loss of Rs 1.34 crore in the June 2021 quarter
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of -4.34%, vs industry avg of 10.02%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.42% to 0.2%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 85.4%, vs industry avg of 42.9%